G38 (Trandolapril and Verapamil Extended-Release 4 mg / 240 mg)
Pill imprint G38 has been identified as Trandolapril and verapamil hydrochloride extended-release 4 mg / 240 mg.
Trandolapril/verapamil is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with calcium channel blocking agents. There is positive evidence of human fetal risk during pregnancy. Trandolapril/verapamil 4 mg / 240 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- G38
- Strength:
- 4 mg / 240 mg
- Color:
- Brown
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- ACE inhibitors with calcium channel blocking agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0329
- Inactive Ingredients:
- silicon dioxide
corn starch
croscarmellose sodium
ferric oxide red
hypromelloses
lactose monohydrate
povidone
sodium alginate
sodium stearyl fumarate
magnesium stearate
microcrystalline cellulose
More about trandolapril/verapamil
Consumer resources
- Other brands: Tarka
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
